BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7203918)

  • 1. Contrast media in body computed tomography: experimental and theoretical background background, present limitations, and proposals for improved diagnostic efficacy.
    Dean PB
    Invest Radiol; 1980; 15(6 Suppl):S164-9. PubMed ID: 7203918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of different contrast medium concentrations and injection protocols on quantitative and clinical assessment of FDG-PET/CT in lung cancer.
    Verburg FA; Kuhl CK; Pietsch H; Palmowski M; Mottaghy FM; Behrendt FF
    Eur J Radiol; 2013 Oct; 82(10):e617-22. PubMed ID: 23880426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast enhancement of the pancreas in computed tomography.
    Kivisaari L; Kormano M; Rantakokko V
    J Comput Assist Tomogr; 1979 Dec; 3(6):722-6. PubMed ID: 512104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal vascular and parenchymal contrast enhancement: the current state of the art.
    Fleischmann D; Kamaya A
    Radiol Clin North Am; 2009 Jan; 47(1):13-26. PubMed ID: 19195531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte-specific contrast media for CT. An experimental investigation.
    Bergman A
    Acta Radiol Suppl; 1997; 411():1-27. PubMed ID: 9164354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the findings on computed cranial tomography following intravenous contrast media.
    Davis KR; New PF; Solis OJ; Roberson GH
    Rev Interam Radiol; 1977 Jan; 2(1):15-8. PubMed ID: 866885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging.
    Brechtel K; Klein M; Vogel M; Mueller M; Aschoff P; Beyer T; Eschmann SM; Bares R; Claussen CD; Pfannenberg AC
    J Nucl Med; 2006 Mar; 47(3):470-6. PubMed ID: 16513616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the iodine concentration that yields the highest intravascular enhancement in MDCT angiography.
    Behrendt FF; Pietsch H; Jost G; Palmowski M; Günther RW; Mahnken AH
    AJR Am J Roentgenol; 2013 May; 200(5):1151-6. PubMed ID: 23617503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation and contrast enhancement of gynecologic organs and tumors in CT.
    Kormano MJ; Goske MJ; Hamlin DJ
    Eur J Radiol; 1981 Nov; 1(4):307-11. PubMed ID: 7346277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of body mass index and gender on coronary arterial attenuation with fixed iodine load per body weight at dual-source CT coronary angiography.
    Zhu X; Zhu Y; Xu H; Tang L; Xu Y
    Acta Radiol; 2012 Jul; 53(6):637-42. PubMed ID: 22798383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive imaging of the coronary arteries using a 64-row multidetector CT scanner: initial clinical experience and radiation dose concerns.
    Francone M; Napoli A; Carbone I; Cavacece M; Nardis PG; Lanciotti K; Visconti S; Bertoletti L; Di Castro E; Catalano C; Passariello R
    Radiol Med; 2007 Feb; 112(1):31-46. PubMed ID: 17310293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late enhancement on cardiac computed tomography in a patient with cardiac sarcoidosis.
    Muth G; Daniel WG; Achenbach S
    J Cardiovasc Comput Tomogr; 2008; 2(4):272-3. PubMed ID: 19083960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of contrast enhancement in thoracic MDCT.
    Bae KT
    Radiol Clin North Am; 2010 Jan; 48(1):9-29. PubMed ID: 19995627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast enhancement by bolus technique in the CT examination of the kidney.
    Baert AL; Wilms G; Marchal G; De Mayer P; De Somer F
    Radiologe; 1980 Jun; 20(6):279-87. PubMed ID: 7403494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic potential of contrast enhancement pharmacokinetics.
    Dean PB; Kivisaari L; Kormano M
    Invest Radiol; 1978; 13(6):533-40. PubMed ID: 755032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contrast media enhancement in cranial computed tomography --studies of iodinated contrast infusion (ICI)].
    Sato O; Kanazawa I; Kamitani H; Yamashita M; Sano K
    No To Shinkei; 1976 Nov; 28(11):1225-33. PubMed ID: 1036028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary masses: contrast enhancement.
    Littleton JT; Durizch ML; Moeller G; Herbert DE
    Radiology; 1990 Dec; 177(3):861-71. PubMed ID: 2244002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A strategy for the contrast enhancement of malignant tumors using dynamic computed tomography and intravascular pharmacokinetics.
    Young SW; Turner RJ; Castellino RA
    Radiology; 1980 Oct; 137(1 Pt 1):137-47. PubMed ID: 7422835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced computed tomography in carcinoma of the urinary bladder. The use of different injection methods.
    Sager EM; Fossä SD; Kaalhus O; Talle K
    Acta Radiol; 1987; 28(1):67-70. PubMed ID: 2952145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.